Table 2.
Follow-up outcomes (after inverse probability treatment weighting) in patients with peripheral arterial occlusive disease who participated (n=162) and did not participate (n=229) in the telemedicine program.
| Outcome | Telemedicine event rate, %/IDa (95% CI) |
Nontelemedicine, event rate, %/ID (95% CI) |
ARDb
(95% CI) |
HRc of telemedicine (95% CI) |
P value | |
| One-year follow-up | ||||||
| All-cause readmission | 37.8/55.8 (46.8 to 64.8) | 39.3/59.6 (50.2 to 69.0) | –0.38 (–1.68 to 0.92) | 0.93 (0.75 to 1.17) | .55 | |
| HFHd | 3.7/4.1 (2.3 to 6.8) | 4.3/4.8 (2.8 to 7.7) | –0.71 (–3.84 to2.42) | 0.85 (0.42 to 1.73) | .66 | |
| ACSe | 1.6/1.7 (0.6 to 3.7) | 2.3/2.5 (1.1 to 4.7) | –0.76 (–2.88 to 1.36) | 0.69 (0.25 to 1.94) | .48 | |
| Stroke | 0.9/0.9 (0.2 to 2.6) | 3.5/3.9 (2.1 to 6.6) | –2.99 (–5.29 to 0.68) | 0.24 (0.07 to 0.80) | .02 | |
| Composite outcome | 2.4/ 2.7 (1.3 to 5.0) | 5.2/ 5.8 (3.6 to 8.9) | –3.14 (–6.19 to 0.09) | 0.46 (0.21 to 0.997) | .049 | |
| End of follow-up | ||||||
| All-cause readmission | 62.2/ 35.5 (31.2 to 40.3) | 62.6/ 38.1 (33.4 to 43.1) | –2.5 (–9.1 to –4.0) | 0.95 (0.79 to 1.13) | .56 | |
| HFH | 10.1/ 3.1 (2.2 to 4.3) | 7.6/ 2.6 (1.7 to 3.7) | 0.55 (–0.79 to1.90) | 1.25 (0.78 to 2.02) | .36 | |
| ACS | 3.0/ 0.9 (0.5 to 1.6) | 2.9/ 1.0 (0.5 to 1.7) | –0.04 (–0.80 to 0.73) | 0.96 (0.43 to 2.17) | .92 | |
| Stroke | 4.4/ 1.4 (0.8 to 2.2) | 7.7/ 2.6 (1.8 to 3.7) | –1.24 (–2.37 to 0.11) | 0.52 (0.28 to 0.93) | .03 | |
| Composite outcome | 7.5/ 2.3 (1.6 to 3.4) | 9.4/ 3.2 (2.3 to 4.4) | –0.86 (–2.20 to 0.48) | 0.72 (0.44 to 1.17) | .18 | |
aID: incidence density.
bARD: absolute risk difference.
cHR: hazard ratio.
dHHF: hospitalization for heart failure.
eACS: acute coronary syndrome.